Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/1995
08/24/1995WO1995022329A1 Agent for prophylaxis and treatment of thromboxane a2-mediated diseases
08/24/1995WO1995022322A1 Sexual steroid-containing transdermal therapeutic systems
08/24/1995WO1995022321A1 Desogestrel-containing transdermal application agent
08/24/1995DE4405899A1 Mittel zur transdermalen Applikation enthaltend Desogestrel Means for transdermal administration comprising desogestrel
08/24/1995DE4405898A1 Transdermale therapeutische Systeme enthaltend Sexualsteroide Transdermal therapeutic systems containing sex steroids
08/24/1995CA2183562A1 Intracellular signalling mediators
08/24/1995CA2183544A1 Desogestrel-containing transdermal application agent
08/23/1995EP0668279A2 6-Azaindole thromboxane synthase inhibitors
08/23/1995EP0667784A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring
08/23/1995EP0667775A1 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
08/23/1995EP0667769A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
08/23/1995CN1107156A Methods of inhibiting uterine fiberosis
08/23/1995CN1107146A A process for preparing a composition containing benzoheterocycles
08/23/1995CN1107043A Methods for inhibiting endometriosis
08/22/1995US5444081 Treatment of hypertension, congestive heart failure, renal failure, glaucoma
08/22/1995US5444080 Hypotensive agents
08/22/1995US5444069 Imidazo-pyridine angiotensin II antagonists used to treat memory loss
08/19/1995CA2142513A1 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
08/17/1995WO1995021860A1 Methods for variation of chromatin condensation
08/17/1995WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
08/17/1995WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021608A1 Use of insulin sensitisers for treating renal diseases
08/17/1995CA2182986A1 Use of insulin sensitisers for treating renal diseases
08/17/1995CA2141506A1 Cosmetic or pharmaceutical compositions containing liposomes
08/16/1995EP0667347A1 Beta-carboline thromboxane synthase inhibitors
08/16/1995EP0667154A1 Use of flavolignans as adjuvants in the therapy of tumors
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists
08/16/1995CN1106812A Tricyclic diazepine vasopressin antagonists
08/16/1995CN1106805A Sulfonamide endothelin antagonists
08/16/1995CN1106804A 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives
08/16/1995CN1106802A Tricyclic benzazepine vasopressin antagonists
08/16/1995CN1106663A Thienopyrimidine derivatives, their production and use
08/15/1995US5441986 Estrogen agonists as remedies for prostate and cardiovascular diseases
08/15/1995US5441985 Administring tomoxetin for incontinence; negligible anti-cholinergic effect
08/15/1995US5441966 Methods of inhibiting Turner's syndrome
08/10/1995WO1995020972A1 Treatment of ovarian estrogen dependent conditions
08/09/1995EP0666271A1 Type 1 and type P fimbriae-adhesins isolated from novel E. coli strains, process for their preparation and uses thereof
08/09/1995EP0665834A1 Quinolone and acridinone derivatives for the treatment of urinary incontinence
08/09/1995EP0665833A1 Dopamine receptor subtype ligands
08/09/1995EP0601123B1 Low speed model following velocity command system for rotary wing aircraft
08/09/1995CN1106381A Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same
08/08/1995US5440036 1,4-benzoxazine derivatives
08/08/1995US5439931 Administering a stimulants to increase sexual drive
08/08/1995US5439919 Treatment of urinary incontinence
08/08/1995US5439895 4-aminoquinazoline derivatives
08/08/1995CA1336579C Delivery systems for the controlled administration of lhrh analogs
08/03/1995WO1995020579A1 Cyanoguanidines as k-channel blockers
08/03/1995WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2179036A1 Cyanoguanidines as k-channel blockers
08/02/1995EP0665227A1 Polyhydronorharman synthase inhibitors
08/02/1995EP0664811A1 Gestagenically active 19,11-bridged 4-estrenes.
08/02/1995EP0664801A1 Amide derivatives
08/02/1995EP0664700A1 Treatment of cachexia and inhibition of il-6 activity
08/02/1995CN1106007A Novel sulfonylamino pyrimidines
08/01/1995US5438134 Process for the production of unsaturated 17 α-cyanomethyl-17 β-h
08/01/1995US5438063 Hypotensive agents, cardiac insufficiency, increased intraocular pressure, and CNS disorders
08/01/1995US5438048 Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation
08/01/1995CA2141231A1 6-azaindole thromboxane synthase inhibitors
08/01/1995CA2140953A1 Polyhydronorharman synthase inhibitors
08/01/1995CA1336492C Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon
07/1995
07/27/1995WO1995019978A1 Tetracyclic derivatives, process of preparation and use
07/27/1995WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
07/27/1995WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/26/1995EP0664125A1 Inhibition of myeloperoxidase activity
07/26/1995EP0664124A1 Treatment of atrophy of the skin and vagina
07/26/1995EP0664122A1 Inhibition of imperfect tissue repair
07/26/1995EP0663827A1 Tocolytic oxytocin receptor antagonists
07/26/1995EP0663822A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
07/25/1995US5436233 Nervous system disorders
07/25/1995US5436137 Promoting fertilization
07/25/1995CA2140813A1 Use of flavolignans as adjuvants in tumor therapy
07/25/1995CA2140722A1 Beta-carboline thromboxane synthase inhibitors
07/25/1995CA2022323C Excretion of potassium ion by prostanoic acid derivatives
07/25/1995CA1336403C Human relaxin formulation
07/25/1995CA1336400C Method for treating renal diseases
07/20/1995WO1995019434A1 Tissue-specific enhancer active in prostate
07/20/1995WO1995019431A1 Zinc finger protein derivatives and methods therefor
07/20/1995WO1995019372A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/19/1995EP0663398A1 Dihydrate of N-(4-amino-6,7-dimethoxyquinazol-2-yl)-N-methyl-N'-(tetrahydrofuroyl-2)-propylene diamine hydrochloride (= alfuzosin hydrochloride dihydrate) and a process for the preparation
07/19/1995EP0663014A1 Dna encoding human alpha 1 adrenergic receptors and uses thereof
07/19/1995EP0662950A1 Benzenealkanoic acids for cardiovascular diseases
07/19/1995EP0662834A1 Novel epoxide-containing compounds
07/18/1995US5434176 Phenylimidazolidines
07/18/1995US5434173 Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity
07/18/1995US5434162 Quinolinyl/isoquinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
07/13/1995WO1995018803A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
07/13/1995CA2180360A1 Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity
07/12/1995EP0662325A2 Inhibition of ovarian dysgenesis, delayed puberty, or sexual infantilism
07/12/1995EP0661994A1 Method of prophylaxis of acute renal failure
07/12/1995EP0661971A1 Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
07/12/1995EP0661970A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
07/12/1995CN1104888A Pharmaceutical composition for preventing or treating arteriosclerosis
07/06/1995WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof
07/06/1995WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof
07/06/1995WO1995018128A1 Pyrazolopyridine adenosine antagonists
1 ... 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 ... 562